Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
Status:
Completed
Trial end date:
2017-09-27
Target enrollment:
Participant gender:
Summary
This is a sequential efficacy and safety study in pediatric patients with type 1 diabetes.
Subjects will be administered insulin to induce a low normal glycemic state and will then
receive an age-appropriate dose of G-Pen (glucagon injection) in a clinical research center
(CRC) or comparable setting.